ETrade Capital Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

ETrade Capital Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$843K	Sell	15,863 -515	-3%	-$30.7K	0.02%	425
2020 Q2	$954K	Sell	16,378 -139	-0.8%	-$7.47K	0.02%	366
2020 Q1	$651K	Sell	16,517 -274	-2%	-$16K	0.02%	398
2019 Q4	$999K	Sell	16,791 -430	-2%	-$23.1K	0.02%	362
2019 Q3	$916K	Sell	17,221 -1,670	-9%	-$85.7K	0.02%	373
2019 Q2	$965K	Sell	18,891 -119	-0.6%	-$5.54K	0.03%	356
2019 Q1	$984K	Buy	+19,010	New	+$922K	0.03%	331

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

ETrade Capital Management's SYNH Position: Q3 2020 in Review

ETrade Capital Management reduced its Syneos Health, Inc. Class A Common Stock (SYNH) stake by 3.1% in Q3 2020, selling an estimated $30.7K and leaving 15,863 shares worth $843K. The position accounts for 0.02% of the portfolio, ranked #425.

ETrade Capital Management first reported a position in SYNH in Q1 2019 and has held it in 7 quarters since. The position peaked at $999K in Q4 2019. 300 funds tracked by Wall St. Rank hold SYNH as of Q3 2020.

ETrade Capital Management held 15,863 shares of Syneos Health, Inc. Class A Common Stock worth $843K as of Q3 2020.
ETrade Capital Management sold 515 Syneos Health, Inc. Class A Common Stock shares in Q3 2020, an estimated $30.7K.
Syneos Health, Inc. Class A Common Stock made up 0.02% of ETrade Capital Management's portfolio in Q3 2020, its #425 holding.
ETrade Capital Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2019 and has held it in 7 quarters since.
ETrade Capital Management's Syneos Health, Inc. Class A Common Stock position peaked at $999K in Q4 2019.
300 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.